PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
06-Oct-2025 EyeCare Partners to Showcase Optometric Expertise and Innovation at the American Academy of Optometry (AAO) Academy 2025 Boston Businesswire
06-Oct-2025 Empowering Brands with Bio-Based Innovation: Braskem Highlights I'm green™ bio-based Portfolio at Sustainable Brands Businesswire
06-Oct-2025 Top Government Lawyers Chart New Path in Private Practice at Scale LLP Businesswire
06-Oct-2025 GoodRx Expands Affordable Access to Repatha® with Nearly 60% Savings Businesswire
06-Oct-2025 ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide ACCESS Newswire
06-Oct-2025 Vaccine Manufacturing GMP (Good Manufacturing Practice) Principles in Training Course (Dec 10th - Dec 11th, 2025) - ResearchAndMarkets.com Businesswire
06-Oct-2025 BrightSpec Names Rick Gordon as CEO Businesswire
06-Oct-2025 A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products Online Training Course (Nov 4, 2025) - ResearchAndMarkets.com Businesswire
06-Oct-2025 Niagen Bioscience Increases Full Year 2025 Net Sales Outlook to 25% to 30% Year-Over-Year Growth Businesswire
06-Oct-2025 Orca Bio Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for Orca-T® to Treat Hematological Malignancies Businesswire
06-Oct-2025 GordonMD Global Investments® Backs Star Therapeutics in $125 Million Series D Financing Businesswire
06-Oct-2025 Algen Biotechnologies Announces Multi-Target Partnership to Advance AI-Powered Drug Discovery in Immunology with AstraZeneca Businesswire
06-Oct-2025 Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorization Application by European Medicines Agency for ADL-018, a Proposed Biosimilar to XOLAIR® (omalizumab) Businesswire
06-Oct-2025 Revvity to Hold Earnings Call on Monday, October 27, 2025 Businesswire
06-Oct-2025 I2Pure Celebrates Zimmer Biomet's Historic Approval of Iodine-Treated Implant System & Confirms AAHKS Attendance Businesswire
06-Oct-2025 Applied DNA Sciences to Begin Trading Under New Ticker ‘BNBX’ Reflecting Digital Asset Treasury Strategy Businesswire
06-Oct-2025 Arcus Biosciences Presents New Data for its HIF-2a Inhibitor Casdatifan and Discloses First Inflammation Programs at Investor Event Businesswire
06-Oct-2025 API Innovation Center Report Spotlights Cross-Sector Dialogue on Drug Shortages Businesswire
06-Oct-2025 TCG Crossover (“TCGX”) Announces Oversubscribed $1.3B TCGX Fund III Businesswire
06-Oct-2025 Mytos Launches Automated CDMO for Scalable, Low-Cost Manufacturing of Stem-Cell Derived Therapies Businesswire